Financhill
Back

Cabaletta Bio Quote, Financials, Valuation and Earnings

Sell
28

CABA
Cabaletta Bio

Last Price:
12.34
Seasonality Move:
15.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Cabaletta Bio Price Quote

$12.34
-0.01 (-2.22%)
(Updated: May 18, 2024 at 5:39 AM ET)

Cabaletta Bio Key Stats

Sell
28
Cabaletta Bio (CABA) is a Sell

Day range:
$12.25 - $12.83
52-week range:
$9.02 - $26.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.69%

Volume:
944.9K
Avg. volume:
1.3M
1-year change:
1.81%
Market cap:
$596.2M
Revenue:
$0
EPS:
$-1.72

How Much Does Cabaletta Bio Make?

Data Unavailable

Is Cabaletta Bio Growing As A Company?

Data Unavailable

Cabaletta Bio Stock Price Performance

  • Did Cabaletta Bio Stock Go Up Last Month?
    Cabaletta Bio share price went down by -18.48% last month
  • Did CABA's Share Price Rise Over The Last Year?
    CABA share price rose by 1.81% over the past 1 year

What Is Cabaletta Bio 52-Week High & Low?

Cabaletta Bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cabaletta Bio?

  • How Much Debt Does Cabaletta Bio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cabaletta Bio Have?
    Cash and short term investments quarterly total is $223.8M
  • What Is Cabaletta Bio’s Book Value Per Share?
    Book value per share is 4.74

Is Cabaletta Bio Cash Flow Positive?

  • What Is CABA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$64.9M
  • What Is Cabaletta Bio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $194.3M
  • What Is Cabaletta Bio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$47.9M

Cabaletta Bio Return On Invested Capital

Data Unavailable

Cabaletta Bio Earnings Date & Stock Price

Cabaletta Bio Competitors

  • Who Are Cabaletta Bio's Competitors?
    Below is a list of companies who compete with Cabaletta Bio or are related in some way:
    • ACADIA Pharmaceuticals Inc (ACAD)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Editas Medicine Inc (EDIT)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Vertex Pharmaceuticals Inc (VRTX)

Cabaletta Bio Dividend Yield

Data Unavailable

Cabaletta Bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -17.28%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 34.00
Upside from Last Price: 175.3%

Major Shareholders

  • How many CABA shares are owned by institutional investors?
    70M CABA shares are owned by institutional investors
  • How many CABA shares are owned by insiders?
    1.2M CABA shares are owned by insiders